HK1220605A1 - 使用抗 抗體治療克羅恩氏病的方法 - Google Patents

使用抗 抗體治療克羅恩氏病的方法

Info

Publication number
HK1220605A1
HK1220605A1 HK16108609.8A HK16108609A HK1220605A1 HK 1220605 A1 HK1220605 A1 HK 1220605A1 HK 16108609 A HK16108609 A HK 16108609A HK 1220605 A1 HK1220605 A1 HK 1220605A1
Authority
HK
Hong Kong
Prior art keywords
antibody
methods
crohns disease
treating
treating crohns
Prior art date
Application number
HK16108609.8A
Other languages
English (en)
Inventor
Wei-Jian Pan
Wayne Tsuji
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of HK1220605A1 publication Critical patent/HK1220605A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
HK16108609.8A 2013-03-15 2016-07-20 使用抗 抗體治療克羅恩氏病的方法 HK1220605A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361789976P 2013-03-15 2013-03-15
PCT/US2014/018308 WO2014143540A1 (en) 2013-03-15 2014-02-25 Methods for treating crohn's disease using an anti-il23 antibody

Publications (1)

Publication Number Publication Date
HK1220605A1 true HK1220605A1 (zh) 2017-05-12

Family

ID=50236361

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108609.8A HK1220605A1 (zh) 2013-03-15 2016-07-20 使用抗 抗體治療克羅恩氏病的方法

Country Status (17)

Country Link
US (5) US20160031983A1 (zh)
EP (2) EP2968486A1 (zh)
JP (4) JP2016516686A (zh)
KR (1) KR20150128859A (zh)
CN (1) CN105307675A (zh)
AP (1) AP2015008801A0 (zh)
AU (1) AU2014228553B2 (zh)
CA (1) CA2906384A1 (zh)
CL (1) CL2015002724A1 (zh)
EA (1) EA201591579A1 (zh)
HK (1) HK1220605A1 (zh)
IL (2) IL241343A0 (zh)
NZ (1) NZ712294A (zh)
PH (1) PH12015502133A1 (zh)
SG (2) SG10201805015TA (zh)
TN (1) TN2015000402A1 (zh)
WO (1) WO2014143540A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
JP6126532B2 (ja) 2010-11-04 2017-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗ｉｌ−２３抗体
MX368653B (es) 2012-05-03 2019-10-10 Boehringer Ingelheim Int Anticuerpos anti-il-23p19.
US10507241B2 (en) 2014-07-24 2019-12-17 Boehringer Ingelheim International Gmbh Biomarkers useful in the treatment of IL-23A related diseases
TWI711629B (zh) 2014-09-03 2020-12-01 德商包林格因蓋爾漢國際股份有限公司 靶向IL-23A與TNF-α之化合物及其用途
AR102417A1 (es) 2014-11-05 2017-03-01 Lilly Co Eli Anticuerpos biespecíficos anti-tnf- / anti-il-23
JP2018507868A (ja) * 2015-02-26 2018-03-22 ジェネンテック， インコーポレイテッド インテグリンベータ７アンタゴニスト及びクローン病の治療方法
TWI733695B (zh) * 2015-09-18 2021-07-21 德商百靈佳殷格翰國際股份有限公司 治療發炎性疾病之方法
US10765724B2 (en) * 2016-03-29 2020-09-08 Janssen Biotech, Inc. Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
EP3848390A1 (en) * 2016-10-14 2021-07-14 Boehringer Ingelheim International GmbH Methods of treating diseases
US20210277105A1 (en) * 2018-07-13 2021-09-09 Astrazeneca Collaboration Ventures, Llc Treating ulcerative colitis with brazikumab
TW202103734A (zh) 2019-04-22 2021-02-01 美商美國禮來大藥廠 治療克隆氏症（ｃｒｏｈｎ＇ｓ ｄｉｓｅａｓｅ）的方法
EP4017880A4 (en) * 2019-08-21 2023-10-11 Astrazeneca Collaboration Ventures, LLC USE OF BRAZIKUMAB TO TREAT CROHN'S DISEASE
CN111956606B (zh) * 2020-08-31 2021-05-14 江苏荃信生物医药有限公司 包含高浓度抗人白介素23单克隆抗体的低粘度液体制剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
PE20000183A1 (es) 1997-07-25 2000-03-11 Schering Corp Citoquinas de mamiferos y reactivos relacionados
EP3501537A1 (en) 2005-06-30 2019-06-26 Janssen Biotech, Inc. Anti-il23 antibodies, compositions, methods and uses
WO2007024846A2 (en) 2005-08-25 2007-03-01 Eli Lilly And Company Anit-il-23 antibiodies
US20070050011A1 (en) 2005-08-26 2007-03-01 Medlogics Device Corporation Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs
EP2354160A1 (en) 2005-08-31 2011-08-10 Schering Corporation Engineered anti-IL-23-antibodies
US7686047B2 (en) * 2005-11-04 2010-03-30 Roger Cleveland Golf Co., Inc. Golf club cover
PL1971366T3 (pl) 2005-12-29 2015-01-30 Janssen Biotech Inc Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposoby i zastosowanie
US7790862B2 (en) 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
BRPI0807710B1 (pt) 2007-02-23 2021-12-14 Merck Sharp & Dohme Corp Anticorpos que se ligam a il-23p19 e il-23 humana, anticorpo, ácido nucleico isolado, vetor de expressão, célula hospedeira microbiana, método de produção de um polipeptídeo e composição farmacêutica
SG178804A1 (en) 2007-02-23 2012-03-29 Schering Corp Engineered anti-il-23p19 antibodies
AR068723A1 (es) 2007-10-05 2009-12-02 Glaxo Group Ltd Proteina que se une a antigenos que se une a il-23 humana y sus usos
US20090117289A1 (en) * 2007-10-09 2009-05-07 Enerize Corporation Method and apparatus for deposition of thin film materials for energy storage devices
WO2009082624A2 (en) 2007-12-10 2009-07-02 Zymogenetics, Inc. Antagonists of il-17a, il-17f, and il-23 and methods of using the same
EP2274333A4 (en) * 2008-03-18 2011-06-15 Abbott Lab PROCESS FOR TREATING PSORIASIS
JP5931442B2 (ja) 2008-08-27 2016-06-08 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． 操作された抗ＩＬ−２３ｐ１９抗体の凍結乾燥製剤
CA2757237A1 (en) 2009-04-01 2010-10-14 Jane Elizabeth Clarkson Anti-il-23 immunoglobulins
EP2435480A1 (en) * 2009-05-27 2012-04-04 Ablynx N.V. Biparatopic protein constructs directed against il-23
JO3244B1 (ar) * 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
EA201891433A3 (ru) 2010-01-15 2019-02-28 Кирин-Эмджен, Инк. Состав антитела и терапевтические режимы
CA2805653A1 (en) 2010-07-20 2012-01-26 Cephalon Australia Pty Ltd Anti-il-23 heterodimer specific antibodies
US9717791B2 (en) * 2010-10-08 2017-08-01 Novartis Ag Methods of treating psoriasis using IL-17 antibody
JP6126532B2 (ja) 2010-11-04 2017-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗ｉｌ−２３抗体
TW201242976A (en) * 2011-01-07 2012-11-01 Abbott Lab Anti-IL-12/IL-23 antibodies and uses thereof

Also Published As

Publication number Publication date
IL241343A0 (en) 2015-11-30
SG11201507483PA (en) 2015-10-29
NZ712294A (en) 2020-04-24
TN2015000402A1 (fr) 2017-01-03
JP2016516686A (ja) 2016-06-09
SG10201805015TA (en) 2018-07-30
WO2014143540A1 (en) 2014-09-18
IL275092A (en) 2020-07-30
EP2968486A1 (en) 2016-01-20
KR20150128859A (ko) 2015-11-18
EP3693007A1 (en) 2020-08-12
CA2906384A1 (en) 2014-09-18
PH12015502133A1 (en) 2016-01-25
JP2023012516A (ja) 2023-01-25
AP2015008801A0 (en) 2015-10-31
US20200017581A1 (en) 2020-01-16
AU2014228553B2 (en) 2019-01-24
AU2014228553A1 (en) 2015-10-08
US20160031983A1 (en) 2016-02-04
US20170218062A1 (en) 2017-08-03
CN105307675A (zh) 2016-02-03
US20200283517A1 (en) 2020-09-10
JP2021107397A (ja) 2021-07-29
CL2015002724A1 (es) 2016-03-28
EA201591579A1 (ru) 2016-01-29
US20180327490A1 (en) 2018-11-15
JP2020073470A (ja) 2020-05-14

Similar Documents

Publication Publication Date Title
IL291446A (en) Anti-trop2 antibodies and methods for their production
HK1220605A1 (zh) 使用抗 抗體治療克羅恩氏病的方法
IL292193A (en) Anti-b7–h1 antibodies for the treatment of tumors
IL245935A0 (en) Methods for RNA analysis
ZA201504861B (en) Apparatus for improved disease detection
PT3088517T (pt) Anticorpo monoclonal neutralizante anti-il-33 humano
PL3060075T3 (pl) Sposób dostarczania przetarć anatomicznych na odzieży
EP2966854A4 (en) PICTURE GENERATING DEVICE, PICTURE PRODUCTION METHOD AND CORRESPONDING PROGRAM
HK1203857A1 (zh) 生物組織的處理方法
HK1217438A1 (zh) 用於上調抗原表達的方法
IL239689A0 (en) A method for producing antibodies
SI3043814T1 (sl) Antigen in postopek za proizvodnjo le-tega
ZA201506725B (en) Method for producing leather
SG11201508193TA (en) Method for generating extended sequence reads
EP3024482A4 (en) Methods for diagnosing and treating immune disease
EP2954777A4 (en) METHOD FOR PRODUCING A CHIMERIC ANIMAL
HK1223684A1 (zh) 改進抗體穩定性的方法
IL241779A0 (en) Method for protein production
SI3016977T1 (sl) Humana protitelesa proti IL-32
EP2860259A4 (en) PROCESS FOR PRODUCING PROTEIN BY PRECIPITATION
GB201314936D0 (en) Radiolabelling method
HK1215073A1 (zh) 用作評估寶石形狀的方法
EP3029145A4 (en) PROCESS FOR PRODUCTION OF METHACRYLYL-CoA
EP3045547A4 (en) PROCESS FOR PRODUCING NATURAL SKINS
GB201304757D0 (en) Method for resuction in acquisition time for MALSDI imaging by targeted acquisition